Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

34.44 -0.36 (-1.03%)
Streaming Delayed Price Updated: 10:11 AM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
News headline image
Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking ↗
Hims & Hers has drawn scrutiny for selling compounded GLP-1 treatments – lower-cost, unapproved alternatives to blockbuster weight-loss drugs made by Eli Lilly and Novo Nordisk. 
Via Stocktwits
News headline image
3 Profitable Stocks for Long-Term Investors
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline. 
Via StockStory
News headline image
2 Top Stocks to Buy With $500 Right Now ↗
Amazon and Hims & Hers look like good picks for 2026. 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
3 Stocks High on My Watch List to Buy ↗
These are three stocks I am looking to buy. 
Via The Motley Fool
News headline image
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
1 Stock Under $50 with Exciting Potential and 2 We Brush Off
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
News headline image
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
From Hims & Hers
Via Business Wire
News headline image
5 High Short-Interest Stocks to Buy Before Q1 2026 ↗
Via MarketBeat
News headline image
From Hype to P&L: Hospitals Now Buying AI That Pays
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. 
From USA News Group
Via GlobeNewswire
News headline image
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Hims & Hers Continues Major International Expansion With Official Entry Into Canada
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology
From Hims & Hers
Via Business Wire
News headline image
Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip? ↗
The healthcare industry is ripe for disruption. 
Via The Motley Fool
News headline image
Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗
Users pointed to emerging drug pipelines, GLP-1 expansion and rising M&A pressure across the sector. 
Via Stocktwits
News headline image
Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗
Via MarketBeat
News headline image
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies... 
Via StockStory
Topics Economy
News headline image
1 Small-Cap Stock with Exciting Potential and 2 We Avoid
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
MarketBeat Week in Review – 11/17 - 11/21 ↗
Via MarketBeat
News headline image
2 Cash-Heavy Stocks with Competitive Advantages and 1 We Find Risky
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
News headline image
KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds
KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a... 
Via MarketMinute
News headline image
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗
Via MarketBeat
News headline image
Ready For A Rebound? Here Are 10 Oversold Stocks To Watch ↗
Many popular stocks have been beaten down to attractive levels, creating potential opportunities for those eyeing a rebound. 
Via Benzinga
News headline image
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4.9% in the afternoon session after news of increased competition in the weight-loss drug market overshadowed the company’s own positive... 
Via StockStory
News headline image
What's Going On With Hims & Hers Health Shares Monday? ↗
Shares of Hims & Hers are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from the company. 
Via Benzinga
News headline image
Hims & Hers Announces New $250 Million Share Repurchase Program – Retail Sees A Steady Trading Range For The Stock ↗
The latest buyback program follows a $100 million share buyback program in July 2024, which has now been completed. 
Via Stocktwits
News headline image
Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing ↗
Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.